{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:41:15Z","timestamp":1778856075414,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jpba.2019.112953","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T01:56:37Z","timestamp":1571882197000},"page":"112953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Labeled substance P as a neuropeptide reporter substance for enzyme activity"],"prefix":"10.1016","volume":"178","author":[{"given":"Ulrich","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Engl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.112953_bib0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/med.21323","article-title":"Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors","volume":"35","author":"Hallberg","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jpba.2019.112953_bib0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14789450.2017.1366859","article-title":"Molecular signature of Complex Regional Pain Syndrome (CRPS) and its analysis","volume":"14","author":"K\u00f6nig","year":"2017","journal-title":"Exp. Rev. Proteom."},{"key":"10.1016\/j.jpba.2019.112953_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.npep.2016.06.002","article-title":"Characterization of substance P processing in mouse spinal cord S9 fractions using high-resolution quadrupole-orbitrap mass spectrometry","volume":"59","author":"Saidi","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jpba.2019.112953_bib0020","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s11064-011-0559-2","article-title":"Hydrolysis of substance P in the presence of the osteosarcoma cell line SaOS-2: release of free amino acids","volume":"36","author":"Cavazza","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpba.2019.112953_bib0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/oxfordjournals.jbchem.a122599","article-title":"Purification and characterization of a substance P-degrading endopeptidase from rat brain","volume":"104","author":"Endo","year":"1988","journal-title":"J. Biochem."},{"key":"10.1016\/j.jpba.2019.112953_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpba.2017.06.007","article-title":"A vote for robustness: monitoring serum enzyme activity by thin-layer chromatography of dabsylated bradykinin products","volume":"143","author":"Bayer","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.112953_bib0035","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/j.pain.0000000000001503","article-title":"The serum protease network \u2013 one key to understand Complex Regional Pain Syndrome pathophysiology","volume":"160","author":"K\u00f6nig","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpba.2019.112953_bib0040","series-title":"Neuropeptide Reporter Assay for serum, Capillary Blood and Blood Cards","author":"Schreiber","year":"2019"},{"key":"10.1016\/j.jpba.2019.112953_bib0045","first-page":"1","article-title":"Methionine oxidation and reduction in proteins","volume":"1840","author":"Kim","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpba.2019.112953_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/bmc.2746","article-title":"Investigation of the metabolic biotransformation of substance P in liver microsomes by liquid chromatography ion trap mass spectrometry","volume":"27","author":"Pailleux","year":"2013","journal-title":"Biomed. Chrom."},{"key":"10.1016\/j.jpba.2019.112953_bib0055","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jpba.2006.10.005","article-title":"Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS\/MS","volume":"43","author":"Chappa","year":"2007","journal-title":"J. Pharm. Biome. Anal."},{"key":"10.1016\/j.jpba.2019.112953_bib0060","series-title":"Validation Data for the Use of Bradykinin and Substance P Protease Activity Assays With Capillary Blood and Blood Cards","author":"Schreiber","year":"2019"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519319508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519319508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:00:11Z","timestamp":1760000411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519319508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":12,"alternative-id":["S0731708519319508"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.112953","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Labeled substance P as a neuropeptide reporter substance for enzyme activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.112953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112953"}}